Body Weight, Sleep, and Heart Health

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

September 30, 2024

Study Completion Date

December 31, 2024

Conditions
Cardiovascular Risk FactorCircadian DysregulationObesity
Interventions
RADIATION

PET Imaging

Positron Emission Tomography (PET) imaging for research.

BEHAVIORAL

Circadian Study Protocol

5-day circadian study schedule

DRUG

11C-Meta-Hydroxyephedrine (mHED)

11C-meta-hydroxyephedrine will be used during PET imaging to measure cardiac presynaptic norepinephrine transporter function.

DRUG

11C-CGP12177

Cardiac beta adrenergic receptor density will be measured via PET imaging with infusion of 11C-CGP12177.

DRUG

O15-water

Blood flow will be measured via PET imaging with infusion of O15-water.

Trial Locations (1)

97239

Oregon Health & Science University, Portland

All Listed Sponsors
lead

Oregon Health and Science University

OTHER

NCT03388788 - Body Weight, Sleep, and Heart Health | Biotech Hunter | Biotech Hunter